SUMMARY The effect of postnatal age on serum bilirubin binding measurements was studied prospectively in extremely premature infants of 25-28 weeks' gestation. Serum was obtained from 10 infants at birth, 2-4 days of age, 1 week, 2 weeks, 4 weeks, 8 weeks, and 10-13 weeks.
The mechanism of altered albumin-bilirubin binding in neonatal serum has remained an enigma despite extensive studies. It is known that infant serum binds bilirubin only a half to a third as effectively as adult serum.' -At the time of birth, bilirubin binding by infant serum is equivalent at all gestational ages from 26-42 weeks2 but can be adversely affected during the first postnatal week by illness-7 and certain drugs. 8 There is no information available on the long term postnatal course of binding measurements in the preterm infant. This may have importance for the management of prolonged unconjugated hyperbilirubinaemia and give insight into the resolution of infant binding deficiencies.
For these reasons, we have prospectively investigated the ability of serum from a group of very premature infants (25-28 weeks' gestation) to bind bilirubin during the first 3 months of life. Measurements were made serially and related to the clinical course.
Materials and methods
Patient population. Ten premature infants were studied throughout their admission to hospital until discharged home. To be included in this prospective study the following criteria were used: (1) gestational age -28 weeks as assessed by maternal days (range eight-45). By the time of discharge at 10-13 weeks all infants were free of supplemental oxygen and growing well on standard milk formula, weighing at least 2160 g.
Bilirubin binding studies. Serum was obtained at the time of birth (cord blood), 2-4 days of age, 1 week, 2 weeks, 4 weeks, 8 weeks, and predischarge at 10-13 weeks. Serum was protected from light and stored at -4°C until processed.
Albumin concentration was measured by a standard colorimetric method. Total bilirubin concentration was measured spectrophotometrically. 12 The apparent unbound bilirubin concentration (AUBC) was determined by horseradish peroxidase oxidationt2 at 25°C using a Coleman 124 recording spectrophotometer. Bilirubin titration curves were prepared by adding small amounts of an alkaline bilirubin (Sigma, St Louis) solution to aliquots of serum. A range of 10-20 titration points was performed with each specimen. The curves were analysed as described previously2 according to the empiric power curve equation AUBC=aRb, where R is the molar ratio of total bilirubin:albumin. The apparent association constants for the primary and secondary bilirubin binding sites were estimated from Scatchard plots using a standard graphic interpolation method. '3 Mean (SD) rate constant (Kp) for the enzymatic reaction was 2 75 (0.50) AA4tmol/l/min. Coefficients of variation for triplicate determinations were 1-7% for total bilirubin and 5.3% for apparent unbound bilirubin concentration.
Statistical analysis. Data are expressed as mean (SEM) or as median with range or percentiles. All comparisons between groups were made using the paired or unpaired Student t test or the Wilcoxon rank sum test where appropriate. Curvilinear and linear regression analysis was performed using the least squares method with calculation of the appropriate correlation coefficients. For all statistical tests the null hypothesis was considered to be rejected if p<005.
Results
Titration curves of serum are presented as direct plots of the apparent unbound bilirubin concentration (AUBC) against the molar ratio of total bilirubin:albumin (R). By using the molar ratio the effect of differences in albumin concentration among the samples was removed. In comparing titration curves a higher apparent unbound bilirubin concentration at any specified molar ratio indicates diminished binding. Figure 1 presents the results obtained on serum at birth, 1 week, and 10-13 weeks of age. The shape of the titration curves apparently changes with advancing postnatal age.
Using both paired and unpaired testing, the apparent unbound bilirubin concentration at birth and 1 week were significantly different at molar ratios of 0-4, 0-6, 0-8, and 1-0 (all p<0-02), indicating a deterioration in the binding ability of serum at one week compared with the time of birth. By 10-13 weeks postnatally the apparent unbound bilirubin concentration at all values of the molar ratio (0.2, 0-4, 0-6, 0-8, and 1.0) had significantly improved compared with both previous times (p<0.05 in all cases). !imol/l (3 (0.01) g/100 ml) at birth to 537 (SEM 14) [tmol/I (3.7(0-01) g/100 ml) at 3 months (p<0005). (1-37x109M-1) was not significantly different from that for adult serum but was improved over all previous infant measurements (p<0-01 in all cases). There was a significant linear correlation between the apparent unbound bilirubin concentration at molar ratio of 0-6 and the primary association constant (r=0-62, p<0001).
The secondary association constant had a similar postnatal pattern. The secondary association constant at birth (median 1 30x 107M-) declined to a stable level over the first month (0-78-0.84x 107M-1) and then rose at 10-13 weeks of age (median 1-75 x 107M-1) to equal that found in adult serum.
Discussion
We have studied postnatal changes in albuminbilirubin binding in sera from sick, extremely premature infants. There was a prolonged period of diminished binding lasting one month. A subsequent dramatic improvement occurred so that bilirubin binding was equal to that of adult serum by 3 months.
These changes in binding must be interpreted in view of the infants' clinical state. Cashore6 and Ebbesen5 7 have shown that bilirubin binding to albumin could be affected in preterm infants by the presence of illness; altered binding began to show improvement when the illness resolved, but their infants were followed for only six to 10 days after birth.6 7 The infants in our study were less mature at group.bmj.com on September 30, 2017 -Published by http://adc.bmj.com/ Downloaded from birth and had a more prolonged course of illness than the previously reported infants. In general, most of our infants 'turned the corner' toward a more healthy state between 4 and 8 weeks. At 4 weeks we would consider that nine out of 10 of our infants were still ill in that six were receiving ventilator/oxygen support, three were being treated for suspected or proven sepsis, and two were recovering from episodes of intestinal dysfunction. By 8 weeks most of these problems had resolved so that only two were receiving supplemental oxygen for bronchopulmonary dysplasia, and all were tolerating full enteral feedings. Thus it seems that the improved bilirubin binding that occurred at 8 weeks may have been due to a resolution of factors related to illness. However, it could be totally independent of illness and be a coincidental postnatal effect. To answer this question would require a similar long term serial study in preterm infants who have even more chronic disease.
By 3 months the serum of our preterm infants had binding characteristics indistinguishable from that of adult sera. Kapitulnik 
